TITLE

A pilot study combining individual-based smoking cessation counseling, pharmacotherapy, and dental hygiene intervention

AUTHOR(S)
Gonseth, Semira; Abarca, Marcelo; Madrid, Carlos; Cornuz, Jacques
PUB. DATE
January 2010
SOURCE
BMC Public Health;2010, Vol. 10, p348
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: Dentists are in a unique position to advise smokers to quit by providing effective counseling on the various aspects of tobacco-induced diseases. The present study assessed the feasibility and acceptability of integrating dentists in a medical smoking cessation intervention. Methods: Smokers willing to quit underwent an 8-week smoking cessation intervention combining individual-based counseling and nicotine replacement therapy and/or bupropion, provided by a general internist. In addition, a dentist performed a dental exam, followed by an oral hygiene treatment and gave information about chronic effects of smoking on oral health. Outcomes were acceptability, global satisfaction of the dentist's intervention, and smoking abstinence at 6-month. Results: 39 adult smokers were included, and 27 (69%) completed the study. Global acceptability of the dental intervention was very high (94% yes, 6% mostly yes). Annoyances at the dental exam were described as acceptable by participants (61% yes, 23% mostly yes, 6%, mostly no, 10% no). Participants provided very positive qualitative comments about the dentist counseling, the oral exam, and the resulting motivational effect, emphasizing the feeling of oral cleanliness and health that encouraged smoking abstinence. At the end of the intervention (week 8), 17 (44%) participants reported smoking abstinence. After 6 months, 6 (15%, 95% CI 3.5 to 27.2) reported a confirmed continuous smoking abstinence. Discussion: We explored a new multi-disciplinary approach to smoking cessation, which included medical and dental interventions. Despite the small sample size and non-controlled study design, the observed rate was similar to that found in standard medical care. In terms of acceptability and feasibility, our results support further investigations in this field. Trial Registration number: ISRCTN67470159
ACCESSION #
52039510

 

Related Articles

  • Smoking Cessation Quitlines in Europe: Matching Services to Callers Characteristics. Willemsen, Marc C.; van der Meer, Regina M.; Schippers, Gerard M. // BMC Public Health;2010, Vol. 10, p770 

    Background: Telephone quitlines offer a wide range of services to callers, including advice and counsel, and information on pharmacotherapy for smoking cessation. But, little is known about what specific quitline services are offered to smokers and whether these services are appropriately...

  • Bringing smoking cessation to diabetes clinics in Indonesia. NG, NAWI; NICHTER, MARK; PADMAWATI, RETNA SIWI; PRABANDARI, YAYI SURYO; MURAMOTO, MYRA; NICHTER, MIMI // Chronic Illness;Jun2010, Vol. 6 Issue 2, p125 

    Objectives: To assess the feasibility of delivering brief and disease-centred smoking cessation interventions to patients with diabetes mellitus in clinical settings. Methods: We conducted a feasibility study involving two interactive smoking cessation interventions: doctor's advice and visual...

  • Telephone-delivered Acceptance and Commitment Therapy for adult smoking cessation: A feasibility study. Bricker, Jonathan B.; Mann, Sue L.; Marek, Patrick M.; Liu, Jingmin; Peterson, Arthur V. // Nicotine & Tobacco Research;Apr2010, Vol. 12 Issue 4, p454 

    Background:: Quitline smoking cessation counseling results in a mere 12% success rate. Testing of new telephone-delivered cessation counseling approaches is needed.

  • Correction: A Text Messaging-Based Smoking Cessation Program for Adult Smokers: Randomized Controlled Trial. Ybarra, Michele; Bosi, A Tülay Bağci; Korchmaros, Josephine; Emri, Salih // Journal of Medical Internet Research;Jun2015, Vol. 17 Issue 6, p1 

    A correction to the article "A Text Messaging-Based Smoking Cessation Program for Adult Smokers: Randomized Controlled Trial" published in a previous issue of the periodical is presented.

  • Long-term follow-up of a high- and a low-intensity smoking cessation intervention in a dental setting- a randomized trial. Nohlert, Eva; Öhrvik, John; Tegelberg, Åke; Tillgren, Per; Helgason, Ásgeir R. // BMC Public Health;2013, Vol. 13 Issue 1, p1 

    Background: Achieving lifelong tobacco abstinence is an important public health goal. Most studies use 1-year follow-ups, but little is known about how good these are as proxies for long-term and life-long abstinence. Also, intervention intensity is an important issue for development of...

  • Long-term effectiveness and cost-effectiveness of smoking cessation interventions in patients with COPD. Hoogendoorn, Martine; Feenstra, Talitha L.; Hoogenveen, Rudolf T.; Rutten-van Mölken, Maureen P. M. H. // Thorax;Aug2010, Vol. 65 Issue 8, p7 

    Background The aim of this study was to estimate the long-term (cost-) effectiveness of smoking cessation interventions for patients with chronic obstructive pulmonary disease (COPD). Methods A systematic review was performed of randomised controlled trials on smoking cessation interventions in...

  • Adherence to Varenicline Among African American Smokers: An Exploratory Analysis Comparing Plasma Concentration, Pill Count, and Self-report. Buchanan, Taneisha S.; Berg, Carla J.; Cox, Lisa Sanderson; Nazir, Niaman; Benowitz, Neal L.; Yu, Lisa; Yturralde, Olivia; Jacob, Peyton; Choi, Won S.; Ahluwalia, Jasjit S.; Nollen, Nicole L. // Nicotine & Tobacco Research;Sep2012, Vol. 14 Issue 9, p1083 

    Introduction: Measuring adherence to smoking cessation pharmacotherapy is important to evaluating its effectiveness. Blood levels are considered the most accurate measure of adherence but are invasive and costly. Pill counts and self-report are more practical, but little is known about their...

  • Four-week pre-quit varenicline ups success rate.  // Pulse;5/18/2011, Vol. 71 Issue 18, p11 

    The article reports on the increase in success rate of smokers who want to quit smoking when using varenicline for four weeks rather than one week before their quit date.

  • Smoking cessation plan shows short-term cost benefits in HK.  // PharmacoEconomics & Outcomes News;7/24/2010, Issue 608, p6 

    The article discusses research study on the cost effectiveness of a low-intensity smoking cessation programme, referencing a study by S. S. Chan and colleagues presented at the 17th World Congress of Cardiology.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics